1.           Introduction. 13

1.1         Scope of the Study. 13

1.2         The Insight Partners Research Report Guidance. 14

1.3         Market Segmentation. 15

1.3.1        North America Acute Lung Injury Market – By Therapy. 17

1.3.2        North America Acute Lung Injury Market – By End User 17

1.3.3        North America Acute Lung Injury Market– By Country. 17

2.           Key Takeaways. 18

3.           Research Methodology. 21

3.1         Coverage. 23

3.2         Secondary Research. 23

3.3         Primary Research. 24

4.           North America Acute Lung Injury Market– Market Landscape. 25

4.1         Overview.. 25

4.2         North America PEST Analysis. 25

4.3         Experts Opinion. 26

5.           North America Acute Lung Injury Market – Key Market Dynamics. 27

5.1         Market Drivers. 27

5.1.1        Rising Prevalence of Respiratory Diseases. 27

5.1.2        Growing Geriatric Population. 28

5.2         Market Restraints. 28

5.2.1        Expensive Therapies. 28

5.3         Market Opportunities. 29

5.3.1        Increasing Technological Advancements by Market Players. 29

5.4         Future Trends. 30

5.4.1        Surging Pipeline Drugs. 30

5.5         Impact Analysis. 30

6.           Acute Lung Injury Market– North America Analysis. 32

6.1         North America Acute Lung Injury Market Revenue Forecast and Analysis. 32

7.           North America Acute Lung Injury Market Analysis – By Therapy. 34

7.1         Overview.. 34

7.2         North America Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028) 34

7.3         Mechanical Ventilation. 35

7.3.1        Overview.. 35

7.3.2        Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 35

7.4         Fluid Management 37

7.4.1        Overview.. 37

7.4.2        Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 37

7.5         Pharmacotherapy. 39

7.5.1        Overview.. 39

7.5.2        Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 39

7.6         Adjunctive Procedures. 41

7.6.1        Overview.. 41

7.6.2        Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 41

8.           North America Acute Lung Injury Market Analysis – By End User 43

8.1         Overview.. 43

8.2         North America Acute Lung Injury Market Revenue Share, by End User (2021 and 2028) 43

8.3         Hospitals. 44

8.3.1        Overview.. 44

8.3.2        Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 44

8.4         Ambulatory Surgery Centers. 46

8.4.1        Overview.. 46

8.4.2        Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 46

8.5         Others. 48

8.5.1        Overview.. 48

8.5.2        Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 48

9.           North America Acute Lung Injury Market – Country Analysis. 50

9.1         North America: Acute Lung Injury Market 50

9.1.1        Overview.. 50

9.1.2        North America: Acute Lung Injury Market, by Country, 2021 & 2028 (%) 52

9.1.2.1          US: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 53

9.1.2.1.1          US: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 54

9.1.2.1.2          US Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million) 55

9.1.2.1.3          US Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million) 55

9.1.2.2          Canada: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 57

9.1.2.2.1          Canada: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 57

9.1.2.2.2          Canada Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million) 58

9.1.2.2.3          Canada Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million) 59

9.1.2.3          Mexico: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 60

9.1.2.3.1          Mexico: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 60

9.1.2.3.2          Mexico Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million) 61

9.1.2.3.3          Mexico Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million) 62

10.        Impact Of COVID-19 Pandemic on North America Acute Lung Injury Market 63

10.1      North America: Impact Assessment of COVID-19 Pandemic. 63

11.        Industry Landscape. 65

11.1      Overview.. 65

11.2      Organic Developments. 65

11.2.1     Overview.. 65

11.3      Inorganic Developments. 67

11.3.1     Overview.. 67

12.        Company Profiles. 68

12.1      GlaxoSmithKline Plc. 68

12.1.1     Key Facts. 68

12.1.2     Business Description. 68

12.1.3     Products and Services. 69

12.1.4     Financial Overview.. 69

12.1.5     SWOT Analysis. 72

12.1.6     Key Developments. 73

12.2      Stemedica Cell Technologies, Inc. 74

12.2.1     Key Facts. 74

12.2.2     Business Description. 74

12.2.3     Products and Services. 75

12.2.4     Financial Overview.. 75

12.2.5     SWOT Analysis. 76

12.2.6     Key Developments. 77

12.3      Windtree Therapeutics, Inc. 78

12.3.1     Key Facts. 78

12.3.2     Business Description. 78

12.3.3     Products and Services. 79

12.3.4     Financial Overview.. 79

12.3.5     SWOT Analysis. 81

12.3.6     Key Developments. 82

12.4      ReAlta Life Sciences, Inc. 83

12.4.1     Key Facts. 83

12.4.2     Business Description. 83

12.4.3     Products and Services. 84

12.4.4     Financial Overview.. 84

12.4.5     SWOT Analysis. 85

12.4.6     Key Developments. 86

12.5      Qx Therapeutics, Inc. 87

12.5.1     Key Facts. 87

12.5.2     Business Description. 87

12.5.3     Products and Services. 88

12.5.4     Financial Overview.. 88

12.5.5     SWOT Analysis. 89

12.5.6     Key Developments. 90

12.6      Angion. 91

12.6.1     Key Facts. 91

12.6.2     Business Description. 91

12.6.3     Products and Services. 92

12.6.4     Financial Overview.. 92

12.6.5     SWOT Analysis. 94

12.6.6     Key Developments. 95

12.7      Asklepion Pharmaceuticals, LLC. 96

12.7.1     Key Facts
. 96

12.7.2     Business Description. 96

12.7.3     Products and Services. 97

12.7.4     Financial Overview.. 97

12.7.5     SWOT Analysis. 98

12.7.6     Key Developments. 99

13.        Appendix
. 100

13.1      About The Insight Partners. 100

13.2      Glossary of Terms

Table 1.             North America Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 33

Table 2.             US Acute Lung Injury Market, by Therapy – Revenue and Forecast to 2028 (USD Million) 55

Table 3.             US Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million) 55

Table 4.             Canada Acute Lung Injury Market, by Therapy -Revenue and Forecast to 2028 (USD Million) 58

Table 5.             Canada Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million) 59

Table 6.             Mexico Acute Lung Injury Market, by Therapy -Revenue and Forecast to 2028 (USD Million) 61

Table 7.             Mexico Acute Lung Injury Market, by End User– Revenue and Forecast to 2028 (USD Million) 62

Table 8.             Organic Developments Done by Companies. 66

Table 9.             Inorganic Developments Done by Companies. 67

Table 10.            Glossary of Terms

Figure 1.           North America Acute Lung Injury Market Segmentation. 15

Figure 2.           North America Acute Lung Injury Market Segmentation, By Country. 16

Figure 3.           North America Acute Lung Injury Market Overview.. 18

Figure 4.           Mechanical Ventilation Segment Held the Largest Share of the Market in 2021. 19

Figure 5.           The US to Show Significant Growth During Forecast Period. 20

Figure 6.           North America PEST Analysis. 25

Figure 7.           North America Acute Lung Injury Market Impact Analysis of Driver and Restraints. 31

Figure 8.           North America Acute Lung Injury Market– Revenue Forecast and Analysis. 32

Figure 9.           North America Acute Lung Injury Market Revenue Share, by Therapy (2021 and 2028) 34

Figure 10.        North America Mechanical Ventilation: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 36

Figure 11.        North America Fluid Management: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 38

Figure 12.        North America Pharmacotherapy: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 40

Figure 13.        North America Adjunctive Procedures: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 42

Figure 14.        North America Acute Lung Injury Market Revenue Share, by End User (2021 and 2028) 43

Figure 15.        North America Hospitals: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 45

Figure 16.        North America Ambulatory Surgery Centers: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 47

Figure 17.        North America Others: Acute Lung Injury Market – Revenue and Forecast to 2028 (US$ Million) 49

Figure 18.        North America: Acute Lung Injury Market, by Key Country – Revenue (2021) (USD Million) 51

Figure 19.        North America: Acute Lung Injury Market, by Country, 2021 & 2028 (%) 52

Figure 20.        US: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 54

Figure 21.        Canada: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 58

Figure 22.        Mexico: Acute Lung Injury Market – Revenue and Forecast to 2028 (USD Million) 61

Figure 23.        Impact of COVID-19 Pandemic in North American Country Markets